3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
22
Prostatic Neoplasms
12
Lung Neoplasms
12
Colorectal Neoplasms
12
Neoplasms
9
Pancreatic Neoplasms
6
Lymphoma
6
Hematologic Neoplasms
6
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Hematopoietic and Lymphatic System Neoplasm
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Papillomavirus Infections
3
Obesity-Related Malignant Neoplasm
3
Obesity
3
Motor Activity
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Carcinoma In Situ
3
Anatomic Stage I Breast Cancer AJCC v8
3
Testicular Neoplasms
2
Smoking Cessation
2
Skin Carcinoma
2
Rectal Neoplasms
2
Pain
2
Overweight
2
Interventions
Specimen Handling
8
pembrolizumab
7
enfortumab vedotin
7
Magnetic Resonance Spectroscopy
6
avelumab
4
Nivolumab
4
Gemcitabine
3
cabozantinib
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
vinflunine
1
tremelimumab
1
tocilizumab
1
tamibarotene
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
copanlisib
1
atezolizumab
1
Watchful Waiting
1
Standard of Care
1
Propranolol
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Methods
×
1 year
×
Clear all
No trials found.